EUVIMEDEUVIMED entdecken
Crossref

Optimization of Fluorescence In Situ Hybridization Protocols in the Era of Precision Medicine

Sarah Kudman, Alissa Semaan iD, Majd Al Assaad, Swarna Gogineni, M Laura Martin, Susan Mathew, Olivier Elemento, David C Wilkes, Juan Miguel Mosquera

Current Protocols · 2024

DOI: 10.1002/cpz1.1093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Protocols, 2024. Verfasst von Sarah Kudman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York. Hauptthemen laut MEDLINE: In Situ Hybridization, Fluorescence, Precision Medicine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Englander Institute for Precision Medicine of Weill Cornell Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluorescence in situ hybridization (FISH) is a cytogenetic assay that is widely used in both clinical and research settings to validate genetic aberrations. Simple in principle, it is based on denaturation and hybridization of a DNA probe and its complementary sequence; however, it is subject to continuous optimization. Here we share how in‐house FISH can be optimized using different control tissues to visualize and ultimately validate common and novel genetic abnormalities unearthed by next‐generation sequencing (NGS). Seven specific FISH probes were designed and labeled, and conditions for eight tissue types and one patient‐derived tumor organoid were optimized. Formalin‐fixed paraffin‐embedded (FFPE) tissue slides were used for each experiment. Slides were first deparaffinized, then placed in a pretreatment solution followed by a digestion step. In‐house FISH probes were then added to the tissue to be denatured and hybridized, and then washed twice. To obtain optimal results, probe concentration, pepsin incubation time, denaturation, and the two post‐hybridization washes were optimized for each sample. By modifying the above conditions, all FISH experiments were optimized in separate tissue types to investigate specific genomic alterations in tumors arising in those tissues. Signals were clear and distinct, allowing for visualization of the selected probes. Following this protocol, our lab has quickly optimized 11 directly labeled in‐house FISH probes to support genetic aberrations nominated by NGS, including most recent discoveries through whole‐genome sequencing analyses. We describe a robust approach of how to advance in‐house labeled FISH probes. By following these guidelines, reliable and reproducible FISH results can be obtained to interrogate FFPE slides from benign, tumor tissues, and patient‐derived tumor organoid specimens. This is of most relevance in the era of NGS and precision oncology. © 2024 Wiley Periodicals LLC. Basic Protocol 1 : Metaphase FISH optimization Support Protocol 1 : In‐house probe labeling and preparation Support Protocol 2 : Metaphase spread preparation Basic Protocol 2 : Optimization of FISH on formalin‐fixed paraffin‐embedded tissue

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

In Situ Hybridization, FluorescencePrecision MedicineHumansParaffin EmbeddingNeoplasmsHigh-Throughput Nucleotide SequencingDNA Probes

Stichwörter der Autor:innen

DNANGS validationfluorescence in situ hybridizationmetaphaseoptimizationprobes

Substanzen

DNA Probes

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York.
  • Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.
  • Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York.

ORCID-Profile: Alissa Semaan

Förderung

  • Englander Institute for Precision Medicine of Weill Cornell Medicine

Zitieren

APA

Kudman, S., Semaan, A., Assaad, M. A., Gogineni, S., Martin, M. L., Mathew, S., Elemento, O., Wilkes, D. C., & Mosquera, J. M. (2024). Optimization of Fluorescence In Situ Hybridization Protocols in the Era of Precision Medicine. Current Protocols. https://doi.org/10.1002/cpz1.1093

Vancouver

Kudman S, Semaan A, Assaad MA, Gogineni S, Martin ML, Mathew S, et al. Optimization of Fluorescence In Situ Hybridization Protocols in the Era of Precision Medicine. Current Protocols. 2024. doi:10.1002/cpz1.1093

BibTeX
@article{Kudman2024,
  author = {Kudman, Sarah and Semaan, Alissa and Assaad, Majd Al and Gogineni, Swarna and Martin, M Laura and Mathew, Susan and Elemento, Olivier and Wilkes, David C and Mosquera, Juan Miguel},
  title = {Optimization of Fluorescence In Situ Hybridization Protocols in the Era of Precision Medicine},
  journal = {Current Protocols},
  year = {2024},
  doi = {10.1002/cpz1.1093}
}
Kostenlos starten →